Shares fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s ...

Roche has pledged to build a giant weight-loss drug factory in the US as part of a $50bn (£37bn) pledge aimed at heading off ...

Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

The filing also showed UnitedHealth CEO Andrew Witty's total compensation for 2024 was $26.3 million, compared with $23.5 ...

Stock futures pointed lower Monday and Treasury yields rose as Wall Street remained on edge over President Donald Trump’s ...

(Reuters) -Regeneron Pharmaceuticals said on Tuesday it had entered into a deal valued at more than $3 billion with contract ...

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as ...

Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

Numerous companies have unveiled investments in U.S. manufacturing in recent weeks, including TSMC, Eli Lilly, Hyundai Motor ...

In the December quarter, the company's management said it plans to double the firm's pen capacity over the next couple of ...